retatrutide parkinson clinical trial retatrutide parkinson clinical trial Liraglutide once daily versus placebo in Parkinson's disease: a randomized, double-blind, placebo-controlled trial -tarwiahtravel Phase-3-Retatrutide-trial-sees-participants-achieve-up-to-30-weight-loss

In just three weeks, Ive already lost 9 pounds, and for the first time, I actually feel like Im making real progress

The Long-Term Benefits of GLP-1 Medications Beyond Weight Loss Introduction Over the past few years, GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the next-generation retatrutide have become household names

ncbi.nlm.nih.gov/pmc/articles/PMC8017323/ #4

Rasmussen et al., 2021)

If you are comparing insurance-aware GLP-1 programs specifically, our Calibrate vs Found weight loss program comparison covers that decision in more detail

At the other end of the spectrum, some people who take medications for weight loss struggle to get proper nutrition and may experience malnutrition